Pericapsular Nerve Group Block Versus Caudal Block for Postoperative Pain Management in Pediatric Hip Surgery
Ultrasound-Guided Pericapsular Nerve Group Block Versus Ultrasound-Guided Caudal Block for Postoperative Pain Management in Pediatric Hip Surgery; a Randomized Controlled Trail
1 other identifier
interventional
80
1 country
1
Brief Summary
Children can experience substantial pain after hip operations, causing agitation, depression, and sleep disruption, which can have a negative impact on their health. Opioids are associated with several serious side effects that limits its use as solo agents for pain management. Regional blocks such as caudal Block (CB) and pericapsular nerve group (PENG) block in adjuvant with general anaesthesia are alternative perioperative analgesic techniques that lead to lesser side effects, including motor weakness, postoperative nausea and vomiting with decreased opioid consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 10, 2024
CompletedFirst Submitted
Initial submission to the registry
August 13, 2024
CompletedFirst Posted
Study publicly available on registry
August 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2025
CompletedNovember 28, 2025
November 1, 2025
8 months
August 13, 2024
November 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
pain score with FLACC
(Face, Legs, Activity, Cry, and Consolability scale to assess pain in young children. Each category is scored on a 0-2 scale which results in a total score between 0 (lowest pain) and 10 (worst pain).
30 minutes postoperative, 1 hour postoperative, 2 hour postoperative, and 6 hours postoperative
Secondary Outcomes (5)
The duration of the block
immediately after the intervention, up to 24 hours postoperative
the Time to first postoperative rescue analgesia
24 hours postoperative
Total rescue analgesia consumption
24 hours postoperative
The incidence of postoperative adverse effects
24 hours postoperative
Parents satisfaction score
24 hours postoperative
Study Arms (2)
Group P
EXPERIMENTALIn ultrasound-guided pericapsular nerve group block Group , the patient will be positioned in a supine position. The anatomical landmarks, including ilio-pubic eminence, the iliopsoas muscle and tendon, the femoral artery and vein, and the pectineus muscle, will be identified using a 9-12 MHz superficial linear transducer. A lateral to medial in-plane technique will be used to insert a 22-gauge, 50-mm needle. the needle's tip will be positioned at the musculofascial plane, located between the ilio-pubic ramus posteriorly and the psoas tendon anteriorly. Following negative aspiration to avoid intravascular injection, 0.5-1 ml of normal saline will be injected to confirm the correct needle site. A 0.5 ml/kg plain bupivacaine 0.25% will be injected.
Group C
ACTIVE COMPARATORthe caudal epidural block will be established in the lateral decubitus position, the high-frequency linear transducer will be first placed transversely at the midline to obtain a "frog eye" sign view of the sacral cornu, the sacro-coccygeal ligament, the sacrum, and the sacral hiatus. At this position, the USG transducer will be rotated by 90° to obtain a longitudinal view. The needle will be inserted in-plane into the sacral canal and the Local anaesthetics will be injected under real-time visualization by a dose of 0.5 ml/kg plain bupivacaine 0.25%.
Interventions
USG-guided single-shot PENG in a dose of 0.5 ml/kg of 0.25% bupivacaine per side.
USG-guided single-shot CEB in a dose of 0.5 mL/kg of 0.25% bupivacaine.
Eligibility Criteria
You may qualify if:
- child aged 1- 7 years old
- American Society of Anesthesiologists (ASA) physical status I-II
- scheduled for elective hip surgery under general anesthesia
You may not qualify if:
- parents/guardians refusal to participate
- known local anesthetic drug sensitivity,
- bleeding disorders,
- pre-existing infection at the block site, and
- the presence of major cardiac, renal, or hepatic disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
Study Sites (1)
Samar Rafik Mohamed Amin
Banhā, Qalyubia Governorate, 13511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor of anaesthesia and intensive care
Study Record Dates
First Submitted
August 13, 2024
First Posted
August 21, 2024
Study Start
August 10, 2024
Primary Completion
April 1, 2025
Study Completion
April 20, 2025
Last Updated
November 28, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share